Impact of Bruxism Related Arousals on Cardiovascular Risk in Co-morbid Insomnia and Sleep Apnea
Evaluation of Impact of Bruxism Related Arousals on Cardiovascular Risk in Co-morbid Insomnia and Sleep Apnea (COMISA)
1 other identifier
observational
119
1 country
1
Brief Summary
Sleep disordered breathing is a common and serious health problem. According to epidemiological data, it may affect about 20% of adult population. The majority is not aware of the disease. The most common sleep disorder is obstructive sleep apnea (OSA). The essence of OSA are the episodes of airway obstruction repeated many times during sleep, as a result of which the level of partial oxygen in the blood decreases. Apnea episodes end up waking from sleep, causing sleep fragmentation, deep sleep and REM deficiency. Frequent complications of OSA are hypertension, stroke, cardiac arrhythmia, coronary artery disease and pulmonary hypertension. Comorbid Insomnia and Sleep Apnea (COMISA) is a highly prevalent and debilitating disorder that causes additional disturbances in sleep, daytime functioning, and quality of life for patients, and is a significant diagnostic and therapeutic problem for clinicians. Although the presence of COMISA was first noticed by Christian Guilleminault and his colleagues in 1973, it received very little research attention for almost three decades. There is still lack ofclinical trials concerning this topic. An additional problem in apnea patients is the increased incidence of bruxism. Bruxism is associated with increased masticatory muscle activity during sleep, which may be phased or tonic. It is estimated that the incidence of bruxism in the adult population is 13%. The most common symptoms of bruxism include: pathological wear and tooth sensitivity, damage to the periodontium and oral mucosa, muscle pain in the stomatognathic system, headaches and damage to prosthetic restorations. However, the symptoms of bruxism can go unnoticed for a long time, leaving patients often unaware of the problem. The aim of this project is:
- 1.to determine the prevalence of sleep bruxism in COMISA, OSA and insomnia,
- 2.to examine of arousals (type, frequency) in COMISA, OSA and insomnia,
- 3.to investigate the relationship between arousals and blood pressure values and variability, arrhythmias, sinus rhythm variability, vascular endothelial dysfunction, cardiovascular risk in COMISA, OSA and insomnia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 15, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedMarch 28, 2025
March 1, 2025
2.7 years
June 15, 2021
March 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
The incidence of sleep bruxism in obstructive sleep apnea, insomnia and COMISA.
Each participant will undergo audio-video polysomnography to assess sleep bruxism, sleep-related breathing disorders and other sleep parameters. Polysomnograms will be evaluated in a 30-second contributions, according to standard sleep criteria.
01.07.2021-31.12.2022
The meaning of arousals in relationships between sleep bruxism, obstructive sleep apnea, insomnia and COMISA,
Each participant will undergo audio-video polysomnography to assess sleep bruxism, sleep-related breathing disorders and other sleep parameters (especially arousals: type, frequency).
01.07.2021-31.12.2022
Secondary Outcomes (19)
Relationship between sleep bruxism, obstructive sleep apnea and insomnia assessed by Athens Insomnia Scale.
01.07.2021-31.12.2022
Relationship between sleep bruxism, obstructive sleep apnea and insomnia assessed by Insomnia Severity Index.
01.07.2021-31.12.2022
Relationship between sleep bruxism, obstructive sleep apnea, COMISA and pain assessed by Graded Chronic Pain Scale.
01.07.2021-31.12.2022
Relationship between sleep bruxism, obstructive sleep apnea, COMISA and depression assessed by Patient Health Questionnaire - 9.
01.07.2021-31.12.2022
Relationship between sleep bruxism, obstructive sleep apnea, COMISA and sleep quality assessed by Pittsburgh Sleep Quality Index - a self-report questionnaire that assesses sleep quality over a 1-month time interval.
01.07.2021-31.12.2022
- +14 more secondary outcomes
Study Arms (2)
COMISA group
Patients with diagnosed COMISA.
Healthy controlls
Healthy indyviduals.
Interventions
Each of the patients will undergo polysomnography
Eligibility Criteria
Patients with suspicion of COMISA referred to the Department of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology operating at the Wroclaw Medical University. Healthy controls.
You may qualify if:
- age between 18 and 75 years old
- suspicion of COMISA
You may not qualify if:
- age under 18
- age over 75
- terminal general diseases
- severe mental disorders
- taking drugs that could falsify polysomnography
- confirmed alcoholism
- drug addiction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wroclaw Medical University
Wroclaw, Poland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helena Martynowicz, Associate professor
Wroclaw Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
June 15, 2021
First Posted
June 23, 2021
Study Start
June 1, 2021
Primary Completion
January 30, 2024
Study Completion
March 30, 2024
Last Updated
March 28, 2025
Record last verified: 2025-03